GERN Q3 2023 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

Q3 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$164,000-44.8% YoY

Gross Profit

$164,000100.0% margin

Operating Income

-$48M-29031.7% margin

Net Income

-$45M-27320.1% margin

EPS (Diluted)

$-0.08

QoQ Revenue Growth

+465.5%

Cash Flow

Operating Cash Flow

-$51M

Free Cash Flow

-$51M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$413M

Total Liabilities

$122M

Stockholders' Equity

$291M

Cash & Equivalents

$31M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$164,000	$297,000	-44.8%
Gross Profit	$164,000	-$24M	+100.7%
Operating Income	-$48M	-$40M	-19.2%
Net Income	-$45M	-$41M	-9.1%